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Abstract
Methods and Results: The cardiac stem/progenitor cells from adult mice were seeded at low density in serum-free medium.
The colonies thus obtained were expanded separately and assessed for expression of stem cell antigen-1 (Sca-1). Two
colonies each with high Sca-1 (CSH1; 95.9%; CSH2; 90.6%) and low Sca-1 (CSL1; 37.1%; CSL2; 17.4%) expressing cells were
selected for further studies. Sca-1
+ cells (98.4%) isolated using Magnetic Cell Sorting System (MACS) from the hearts were
used as a control. Although the selected populations were similar in surface marker expression (low in c-kit, CD45, CD34,
CD31 and high in CD29), these cells exhibited diverse differentiation potential. Unlike CSH1, CSH2 expressed Nanog, TERT,
Bcrp1, Nestin, Musashi1 and Isl-1, and also showed differentiation into osteogenic, chondrogenic, smooth muscle,
endothelial and cardiac lineages. MACS sorted cells exhibited similar tendency albeit with relatively weaker differentiation
potential. Transplantation of CSH2 cells into infarcted heart showed attenuated infarction size, significantly preserved left
ventricular function and anterior wall thickness, and increased capillary density. We also observed direct differentiation of
transplanted cells into endothelium and cardiomyocytes.
Conclusions: The cardiac stem/progenitor cells isolated by a combined clonal selection and surface marker approach
possessed multiple stem cell features important for cardiac regeneration.
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Introduction
The pioneering work of Anversa et al. has provided an intriguing
evidence of increased mitotic activity in the cardiomyocytes in
patients with myocardial infarction (MI) besides the existence of
resident population of cardiac stem/progenitor cells [1]. These
results are supported by other research groups to show that
resident stem/progenitor cells have the ability to differentiate into
all cell types required for myocardial regeneration including
cardiomyocytes, smooth muscle cells and endothelial cells [2].
Despite their immense differentiation potential, use of cardiac
stem/progenitor cells is limited due to lack of markers for selection
of a specific stem cell population [3]. Stem cell antigen-1
+ (Sca-1
+)
[3,4], Islet-1
+ (Isl-1
+) [5], c-kit
+1, side population (SP) cells [6,7]
and cardiosphere-derived cells [8] have been extracted from heart
tissue. Nevertheless, there is no distinct relationship between these
reported cardiac stem/progenitor cell populations due to differ-
ence in isolation and characterization methods. Moreover, it
remains to be determined whether these individual stem/
progenitor cell populations represent different intermediate
developmental stages of the same stem/progenitor cells or these
are independent cell lineages which have originated from different
stem/progenitor cell populations. Similarly, their relationship with
the cardiac precursor cells observed during embryonic develop-
ment has not been established [9,10].
In this study, we isolated several sub-populations purified from
adult mouse heart based on clonogenicity and surface marker
expression and investigated the important features of cardiac
stem/progenitor cell population for cardiac differentiation.
Materials and Methods
Ethics statement and the Animals used
C57BL6 mice (Harlan) were used for cell isolation and cell
transplantation models. All animal experiments conformed to the
Guidelines for Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH Publication No. 85-23,
revised 1985) and all protocols of animal experiments were
approved by the Institutional Animal Care and Use Committee,
University of Cincinnati, Protocol #06-03-13-03.
Cell culture
The whole hearts extracted from male C57BL6 mice (12 weeks
old) were perfused and washed several times with ice-cold PBS to
remove the blood cells. Aorta, pulmonary artery, and pericardium
were removed carefully. The hearts were minced and digested for
20-minutes at 37uC with 0.1% type-II collagenase (Invitrogen) and
0.01% DNAse-I (Worthington Biochemical Corporation). The
cells were passed through 40 mm filter, fractionated with
70%Percoll (Fluka) and cultured in maintenance medium
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with B27 (Invitrogen), 20 ng/ml epidermal growth factor (EGF;
Sigma), and 40 ng/ml basic fibroblast growth factor (bFGF;
PeproTech). The cells were collected 1-week later and re-seeded
on new culture dishes with serum-free maintenance medium at a
low density (100cells/cm
2) to initiate colony formation. Sixteen
days later, the colonies thus obtained were transferred into 24-well
dish and cultured individually in expansion medium containing
DMEM/F12 (Invitrogen) supplemented with 2%FBS, B27-
Supplement (Invitrogen), 20 ng/ml EGF (Sigma), 40 ng/ml bFGF
(PeproTech), and 10 ng/ml leukemia inhibitory factor (LIF;
Chemicon). All colony-derived cells were re-seeded on new dishes
after they reached 90–100% confluence and were maintained with
expansion medium.
Sca-1
+ cell-enriched population was also purified from the
heart-derived cells with Magnetic Cell Sorting system anti-Sca-1
MicroBead Kit (Miltenyi Biotec) per instructions of the manufac-
turer and maintained in expansion medium similar to other
colony-derived cell populations.
Flow cytometry
Flow cytometery of the purified cell populations was carried out
as described in Text S1.
Growth function assay
Each cell population was seeded at a density of 1610
4 cells/cm
2
in 1 ml expansion medium on 24-well plate and cultured at 37uC
in humid air with 5% CO2. Cell number was counted on days
1,3,5, and 7 after initial seeding. The doubling time of each cell
population was calculated with the cell numbers on day 1 and 3
[11].
RNA extraction and RT-PCR
Total RNA was extracted from different treatment cell
populations with RNeasy Mini Kit (Qiagen) and cDNA was
generated with Omniscript-RT Kit (Qiagen). Each PCR reaction
was performed with target gene specific primers. We also
performed real-time PCR to determine the expression of VEGF
gene under anoxic conditions using SYBR-Green Master Mix
(BIO-RAD) in a BIO-RAD-iQ5 optical module. The mRNA level
was standardized to inner control (GAPDH) and expressed as fold-
increase versus normoxia condition.
Sphere formation assay
Sphere formation assay was performed as described in Text S1.
Differentiation assay
These cells were cultured in specific differentiation media for
smooth muscle, endothelial cells, cardiomyocyte, osteogenic,
chondrogenic, and adipogenic differentiation as detailed in Text
S1 and detected by specific staining as described earlier [12].
Myocardial infarction model and cell transplantation
Experimental MI was developed in young female C57BL6 mice
(12-weeks old; 20–25 g body weight) by left anterior descending
(LAD) coronary artery ligation [13]. Ten minutes later, 20 ml basal
DMEM/F12 medium without cells (control group) or containing
2610
5cells (Cell Injection group) were injected into infarction and
border zones as described in Text S1.
Echocardiography
The mouse heart function was assessed by transthoracic
echocardiography before surgery (baseline), 1 and 4-weeks after
surgery using 7–15 MHz probe on iE33 Echocardiography system
(Philips) (Please see Text S1).
Morphological analysis
The hearts were prepared for measurement of infarction size,
anterior wall thickness, and percent fibrosis as described earlier
[14] and detailed in Text S1.
Capillary density analysis
Capillary density was determined as described earlier [15] and
detailed in Text S1.
Fate tracking of the transplanted cells and histological
studies
The cells were labeled with red fluorescent nanocrystals,
QtrackerH625 Cell Labeling Kit (Invitrogen) before transplanta-
tion according to manufacturer’s instructions. The hearts were
harvested 1, 2 and 4-weeks after cell transplantation and perfused
with ice-cold PBS. The extracted hearts were cut transversely and
embedded into OCT compound (Sakura Finetek) and frozen with
liquid nitrogen. Semi-thin cryosections (10 mm) were fixed in
acetone at 220uC for 10 minutes and blocked with CAS
BLOCK
TM (Invitrogen). Sections were incubated with anti-von
Willebrand Factor (Chemicon, dilution=1:100) or anti-cardiac
troponin-I (cTn-I) antibody (Santa Cruz; 1:100) for 1-hour at 37uC
and subsequently incubated with secondary antibody conjugated
to Alexa Fluor-488 (Invitrogen) for 1-hour at 37uC. Nuclei were
stained with DAPI.
Co-culture assay for myogenic differentiation
Neonatal rat cardiomyocytes were isolated from 1–3days old rat
pups using Neonatal Cardiomyocyte Isolation System (Worthing-
ton Biochemical Corporation). For co-culture studies, cardiac cells
were stained with QtrackerH625 Cell Labeling Kit (Invitrogen)
and mixed with freshly isolated cardiomyocytes (1:4) and seeded
on the fibronectin-coated chamber slides at a density of 2.5610
4/
cm
2. For co-culture of the purified cardiac stem/progenitor cells
with fixed neonatal cardiomyocytes, freshly isolated cardiomyo-
cytes were seeded on fibronectin-coated chamber slides at a
density of 2610
4/cm
2. After 24-hours culture, cardiomyocytes
were fixed with 0.5%PFA for 15 minutes at room temperature and
washed with PBS [5]. Qtracker-labeled purified cardiac stem/
progenitor cells were seeded on fixed cardiomyocytes at a density
of 5610
3/cm
2. Co-culture of the purified cardiac stem/progenitor
cells with live or fixed-cardiomyocytes were maintained for 6-days
and, cells were fixed with 4%PFA and immunostained for anti a-
sarcomeric actinin.
Statistical analysis
All data were expressed as mean6SD. Comparison between
two mean values was calculated by an unpaired Student 2-tailed t-
test. Comparison between multiple groups was performed by one-
way ANOVA with post hoc analysis. A value of p,0.05 was
considered statistically significant.
Results
Characterization of clonogenic cell populations
The colony-derived cell populations were analyzed for Sca-1
and c-kit expression (Figure 1A). Sca-1 expression varied from
95.9% to 17.4% whereas c-kit expression was barely detected. The
cell isolation procedure was successfully repeated three times to
study the reproducibility of the procedure. We selected two high
Multi-Potent Sca-1
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Sca-1 expressing populations (CSL1 and CSL2). Non-colony-
derived Sca-1
+ cells selected with MACS (MSH) were used
as controls. These cells rarely expressed CD45, a known
hematopoietic lineage marker. Besides, these cells occasionally
expressed hematopoietic progenitor and endothelial cell markers
CD34 and CD31 [16,17] whereas frequently expressed mesen-
chymal stem cell marker CD44. Although all of colony-derived
Figure 1. Characteristics and genetic background of colony-derived cell populations obtained from adult mouse heart. A, Surface
marker expression analysis by flow cytometry. All selected cell populations were analyzed for expression of Sca-1, c-kit, CD45, CD34, CD31, and CD29.
B, Left, Growth curve of individual cell populations in expansion medium. Right, calculated doubling time of individual cell populations (*p,0.01 vs all
other cell populations). Abbreviations: CSH, colony-derived Sca-1 high expression group; CSL, colony-derived Sca-1 low expression group; MSH,
magnetic beads sorted Sca-1 high expression group. C, Expression of stem cell-related genes analyzed by RT-PCR. RNA extracted from mouse
embryonic stem (mES) cells was used as positive control. D, Sphere-like cell cluster formed on ultra-low attaching dish was stained with Ki67 (green)
and DAPI (blue). Bar=100 mm.
doi:10.1371/journal.pone.0025265.g001
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embryonic stem cells, only CSL2 showed significantly longer
doubling-time compared to other cells (Figure 1B). Non-colony-
derived Sca-1 cells, MSH, also showed similar doubling-time.
These results were consistent with the previous reports [18].
Molecular characteristics and clonogenicity of cardiac cell
populations
Gene expression profile showed that these cell populations were
positive for pluripotent stem cell markers Nanog, Telomerase
reverse transcriptase (TERT, which is usually not detectable in
cardiac fibroblasts) [19], and Bcrp1/ABCG2 (which play central
role to form stem cell-enriched ‘‘side population’’) [6] (Figure 1C).
Bmi1 gene, a determinant of self-renewal of hematopoietic and
neural stem cell was also detected [20]. These pluripotency markers
were detectable in all the cell populations, however, the expression
of Nanog and Bcrp1 was obviously weaker in CSH1 cells. These
data suggested that these cells had different genetic characteristics
compared to the cardiac fibroblasts or endothelial cells.
Sphere formation assay ascertained the self-renewal capacity of
the isolated cells [8] and showed sphere-like cell aggregation.
However, sphere formation with homogeneous positive staining
for Ki67 was detected in CSH2 cells only (Figure 1D).
Differentiation potential of the cells into cardiac cell
lineage
We assessed the differentiation potential of these cells into
smooth muscle, endothelial, and cardiac phenotypes. After
stimulation with platelet derived growth factor-BB (PDGF-BB),
these cells showed significant increase in calponin positive cell
count (Figure S1 A–B) which was confirmed by RT-PCR (Figure
S1 C). Two weeks after induction for endothelial cell differenti-
ation, vWF
+ cells were detected only in CSH2, CSL2, and MSH
populations (Figure S2A) whereas we did not observe expression of
endothelial specific markers in any of the cell populations before
induction of differentiation (Figure S2B–C). However, a statisti-
cally significant increase in vWF
+ cells was only observed in CSH2
cells (Figure S2). The expression of endothelial cell specific genes,
CD31, VE-cadherin, and vWF was confirmed by RT-PCR in
CSH2, CSL2, and MSH populations.
Cardiomyogenic differentiation
Quantitative analysis of cardiac MHC
+ cells revealed highest
differentiation potential in CSH2 population (Figure 2A, 2B). At
the baseline, the early cardiac marker gene, Nkx2.5 was detected
only in MSH population (Figure 2C) whereas GATA4 and
MEF2C were detected in all cell populations (Figure 2C). On the
contrary, mature cardiomyocyte marker genes, cardiac a-myosin
heavy chain (a-MHC), cardiac b-myosin heavy chain (b-MHC),
myosin light chain 2a (MLC2a), and myosin light chain-2v
(MLC2v) were undetectable in all cell populations. Cardiogenic
differentiation was attempted with dexamethasone, DMSO, 5-
azacytidine, oxytocine, TGF-b, Wnt1, Wnt5a, BMP2, and FGF4,
individually or in combination with two or more agents. Although
these agents failed to generate mature beating cardiomyocytes
invariably in all the purified cells, stimulation with BMP2
combined with FGF-4 induced cardiac mature marker genes in
several cell populations (Figure 2C). Only CSH2 cell population
showed multiple cardiac genes (Nkx2.5, b-MHC, and MLC2a)
after induction (Figure 2C). MSH population showed only limited
cardiomyogenic gene expression (Figure 2C) despite the expression
of early cardiogenic marker genes Nkx2.5, GATA4, and MEF2c
prior to induction.
Genetic background and differentiation potential of
Sca-1
+ cells
Sca-1 is commonly used for enrichment of haematopoietic stem
cells [21]. Certainly, Sca-1 high expressing population, CSH2,
showed obvious and unique stem/progenitor cell characteristics in
all analyses. However, Sca-1 high expressing population, CSH1,
showed poor potential inspite of similar isolation method, growth
function, and high expression of Sca-1 antigen compared to
CSH2. Differentiation assay showed that these cells failed to
differentiate into adipogenic lineage, whereas CSH2 and MSH
showed obvious differentiation potential into osteogenic and
chondrogenic lineages (Figure 3A). CSH1 did not differentiate
into any of these three different cell lineages.
We also performed gene expression analysis to determine
additional difference between Sca-1 high cell populations. The
gene expression of LIM homeodomain transcription factor islet-1
(Isl1), the marker of cardiac precursor in the developing as well as
postnatal heart [5], was detected in CSH2 and MSH but not in
CSH1 cells (Figure 3B). Since Isl1 is the marker of cells from
secondary heart field in developing heart [9], we checked the
expression of FGF10 and dHand gene which are expressed in the
cells from secondary heart field. All of these three cell populations
were positive for FGF10 and dHand (Figure 3B). On the contrary,
Tbx5 and eHand genes, which are expressed in the cells from
primary heart field [22], were detected only in MSH (Figure 3B).
The expression of neural RNA-binding protein Musashi1, marker
of neural stem/progenitors [22], was also detected in CSH2 and
MSH populations but not in CSH1 cells. In accordance with the
recent publications that the heart harbors neural crest-derived
multipotent stem/progenitor cells, we analyzed the expression of
neural crest-related marker genes AP2a, Pax3, and ErbB3 [23].
Only MSH cells were positive for the three neural crest-related
marker genes. Although all cell populations expressed epithelial-
mesenchymal transition marker genes Snail and Twist [24],
expression of Snail was relatively poor in CSH1 cells.
Transplantation of Sca-1
+ cells into the infarcted heart
Cardiac function. Based on our in vitro data, CSH2 were
used for transplantation studies in experimental mouse model of
MI (Figure 4A). There was no significant difference between cell
injected and control groups in the cardiac function indices (LVFS
and LVEF), dimensions of LV during diastole (LVDd), and
anterior wall thickness (AWT) at base-line levels (Figure 4B). One
week after LAD ligation, both groups showed deterioration of
cardiac function, slight dilatation of LV dimensions, and decrease
of LV wall thickness. However, 4-weeks after LAD ligation, cell
injected group showed significantly improved cardiac function and
increased wall thickness in the infarct area as compared to control
group. Cell transplantation had no significant effect on LV
dilatation after MI.
Four weeks after their respective treatment, significantly
attenuated infarct size was observed in the animals treated with
cardiac stem cells (Figure 4C). The infarct size was 28% of LV wall
in the cell injected group which was significantly smaller as
compared to the control animal hearts wherein the infarct size was
40% of LV wall (n=3/group). On the other hand, the percent
fibrosis area calculated with computer software from the Masson-
trichrome stained heart tissues showed weak tendency of reduction
in the cell transplanted animal hearts, however, reduction was
insignificant as compared to control animals (Figure 4C).
Neovascularization. The number of capillaries and their
number distribution per myocyte were counted at high power
magnification field. Capillary density was increased in border and
infarcted zones of cell transplanted group as compared to control
Multi-Potent Sca-1
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density in the remote zones. To evaluate whether the
neovascularization was induced by some paracrine factors from
transplanted cells, CSH2 cells were stimulated by hypoxia to mimic
the in vivo ischemic environment. After 2-hours hypoxia, there was
2-fold increase in VEGF gene expression in CSH2 cells as
compared to CSH2 cells cultured under normoxia (Figure 5B).
We also observed that 1-week after cell transplantation, nanocrystal
(red) labeled transplanted cells were clearly incorporated into vWF
+
microvesselslocated betweencardiomyofibers(Figure5C).Twoand
4-weeksaftercell transplantation,cells positivefor both nanocrystals
(red) and vWF
+ (green) were detected in infarcted area.
Myogenesis. We tracked cardiomyogenic fate of the
transplanted cells using red fluorescence nanocrystals in vivo for up
to 4-weeks after transplantation. The transplanted cells were
observed only in infarcted area but were not detected in non-
infarcted area (Figure 6A). One week after cell transplantation,
extensive presence of the transplanted cells was observed at the site
ofthecellgraftwhich appearedsmall and round withweakpositivity
for cTn-I (Figure 6B). Two and 4-weeks later, many nanocrystal-
positive cells were aligned parallel to the native microfibers and
expressed cTn-I (Figure 6C). These findings indicated slow and
progressive morphological transformation of transplanted cells into
cardiomyocytes.Despite clearevidence ofdifferentiation potentialof
CSH2 cells into mature cardiomyocytes in vivo, this cell population
failed to adopt mature cardiac phenotype in vitro even if they
expressed cardiomyocyte lineage specific genes and proteins.
However, CSH2 cells co-cultured with cardiomyocytes indeed
transformed into cardiomyocytes (Figure 6D).
Discussion
We report successful isolation of Sca-1
+ cells from adult mice
heart based on their functional competence. The isolated Sca-1
+
Figure 2. Differentiation potential of isolated Sca-1 high or low expressing cell populations. A, All cell populations were stained for
cardiomyocyte specific marker cardiac MHC (green) and DAPI (blue) after induction. White arrow indicated the cells stained positively for cardiac
MHC. Magnification=6400. B, Cardiac MHC positive cells were calculated before induction (control) and after induction (Induction). The positive rate
was presented as ratio of MHC positive cell number to total cell number (*p,0.01 vs control; **p,0.05 vs control; { p,0.05 vs CSL1, CLS2, and MSH).
C, Expression of cardiomyocyte specific genes analyzed by RT-PCR. RNA extracted from whole adult mouse heart (mH) was used as positive control.
Arrow indicated the change of cardiomyocyte specific gene expression after induction.
doi:10.1371/journal.pone.0025265.g002
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great potential for myocardial regeneration in a mouse model of
acute MI. Gene profiling studies suggested that CSH2 cells
originated from precursor cells of secondary heart field and
showed functional superiority in terms of proliferation, clonogeni-
city, self-renewal, and Sca-1 expression besides multiple stem cell-
related genes as compared to MSH. Contrarily, MSH cells,
isolation of which was based on Sca-1 expression alone, were
heterogeneous and contained cell populations from different
sources including primary heart field, secondary heart field, and
neural crest-derived cells.
Purification of a cardiac stem cell population from the heart is
challenging, especially due to lack of specific surface markers. We
therefore exploited clonogenic potential of the stem cells, which is
considered as one of the functional feature of stem/progenitor cells
[25], in combination with Sca-1 expression for their purification.
We cultured the heart-derived cells in serum-free culture
conditions at a very low density which alleviated their cross-
contamination from the presence of mature cells in the culture
besides recovery of sub-clonal cell populations with strong
survivability and proliferation. Interestingly, some of these cell
populations thus obtained showed spontaneous high Sca-1
positivity with very low c-kit expression stem/progenitor cell
marker [1,8]. This may be attributed to the difference in the
culture conditions and different expression period of these two
surface markers during maturation of heart [26]. CSCs in their
undifferentiated status express stem-cell antigens c-kit, MDR1,
and Sca-1 either alone or in combination, however only a small
percentage of cells is positive for anyone of the three antigens
alone [27]. Of these three populations, ckit
+ CSCs are the
most extensively studied and well characterized CSCs for
stemness characteristics including clonogenicity, self renewal and
Figure 3. Multiple differentiation potential of isolated colony-derived Sca-1 high expressing population. A, Differentiation assay of Sca-
1 high expressing populations into mesenchymal cell lineage. Upper panel shows osteogenic differentiation of Sca-1 high expressing populations
with von Kossa staining. Magnification=6320. Lower panel shows chondrogenic differentiation with Toluidine Blue O staining. Magnification=6200.
Inserts show magnified area from same sample. Magnification=61000. B, Gene expression profiles of Sca-1 high expressing cell populations analyzed
by RT-PCR.
doi:10.1371/journal.pone.0025265.g003
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+ progenitor cells
constitute a predominant stem cell population in the heart as
compared to the c-kit
+ cells [1].
We observed that the purified Sca-1
+ cells expressed mature
cardiomyocyte gene markers including b-MHC and MLC2a.
Although a-MHC is predominant isoform of MHC in adult mouse
heart, b-MHC isoform is strongly expressed in both atrial and
ventricular muscle in the developing heart [26]. Additionally,
MLC2a is expressed in myocardial cells during early stage of
cardiac development as one of the earliest marker for differenti-
ated cardiomyocytes [29]. Therefore, the gene expression of b-
MHC and MLC2a markers clearly represented early commitment
to cardiomyogenic lineage.
The purified Sca-1
+ cells also expressed Isl-1 gene, a marker for
secondary heart field [10,22]. Isl-1
+ cells are considered as
cardiovascular precursors with the ability to differentiate into the
three main cardiac cell lineages [9] and post-natal mouse heart
[5]. Brachyury (Bry)
+/Flk-1
+ cells from mouse ES cell derived
Figure 4. Transplantation effect of cardiac multipotent cells into infarction area of mouse heart. A, Schematic representation of the time
course of in vivo experiment. B, Cardiac function and dimensions analyzed by echocardiography. (*p,0.05 vs control). Abbreviations: FS, fractional
shortening; EF, ejection fraction; LVDd, left ventricle end-diastolic dimension; AWT, end-diastolic anterior wall thickness. C, Heart function studies at
four weeks after LAD ligation and cell transplantation. Left upper panels show representative heart sections after Masson’s trichrome staining. Left
lower panel shows calculated infarction size. Middle panel shows anterior wall thickness of infarcted area. Right panel shows area of fibrosis (%)
calculated by computer software. (*p,0.05 vs control).
doi:10.1371/journal.pone.0025265.g004
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Similarly, cardiac progenitor cells from developing mouse embryo
differentiated into smooth muscle cells and cardiomyocytes [26].
Although the definite hierarchy of these reported cardiac
precursor/progenitor cells remains unclear, it is suggested that
Bry
+/Flk-1
+ cells may precede the separation of Isl-1
+ cells and,
the Nkx2.5 expressing progenitor cells may be downstream of the
Bry
+/Flk-1
+ cells and Isl-1
+ cells because of their bi-potential
differentiation capacity [25]. In accordance with our data, CSH2
cell population is positioned between Isl-1
+ and Nkx2.5 due to
expression of Isl-1 and Flk-1, and lack of Nkx2.5 during the
undifferentiated state while these cells expressed Nkx2.5 after
differentiation respectively.
Our in vivo studies in the experimental animal model provided a
clear evidence of differentiation potential of CSH2 cells into
mature cardiomyocytes. We believe that rate of cardiomyogenic
Figure 5. Neovascularization of the infarcted myocardium by cell transplantation. A, Left panels show endothelial cell immunostaining
with anti-vWF (green) and DAPI (blue) of control and cell injection group in border zone and remote zone of infarcted heart. Middle panel shows
quantitative estimation of capillary density expressed as the number of capillaries per high power magnification field. Right panel shows quantitative
estimation of capillary density expressed as capillaries per myocyte. (*p,0.05 vs control). B, Relative mRNA expression level of VEGF under normoxic
and anoxic conditions analyzed by real-time RT-PCR. (*p,0.05 vs control). C, Representative immunostaining of endothelial cells with anti-vWF
(green) one, two, and four weeks after transplantation of nanocrystal-labeled cells (red) to detect direct incorporation of transplanted cells into newly
formed vessels. Bar=50 mm.
doi:10.1371/journal.pone.0025265.g005
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heart would have been better if the cells were transplanted during
chronic phase after LAD ligation when the acute phase
inflammatory responses had subsided. Contrary to the in vivo
data, these cells showed low incidence of differentiation to adopt
mature cardiac phenotype in vitro which may be attributed to lack
of required multiple cues for maturation [31]. A recent report
suggests that a direct contact of cardiac stem/progenitor cells with
Figure 6. Regeneration of cardiomyocytes by cardiac multipotent cell. A, Heart samples were stained for cardiomyocyte-specific marker
cardiac troponin-I (green) one, two, and four weeks after cell transplantation. Transplanted nanocrystal-positive cells (red) accumulated into infarction
area and could not detect in remote area at any time point. Bar=200 mm. B, Representative immunostaining of cTn-I (green) after transplantation of
nanocrystal-labeled cells (red) to detect direct regeneration of cardiomyocytes from transplanted cells at one, two, and four weeks after cell
transplantation. Bar=50 mm. C, Representative immunostaining results for cTn-I (green) using confocal microscope four weeks after transplantation
of nanocrystal-labeled cells (red). Arrows indicate double positive cells for cTn-I and nanocrystal. Bar=20 mm. D, Representative immunostaining of
a-sarcomeric actinin (green) and DAPI (blue) in co-culture system. White arrows in left panels indicate cardiomyocyte (magnified from the white box)
formed from multipotent cardiac cell (double positive for nanocrystal (red) and a-sarcomeric actinin; green) in co-culture system with living
cardiomyocytes. Bar=50 mm. White arrows in right panels indicate double positive cell in co-culture system with PFA-fixed cardiomyocytes.
Bar=50 mm.
doi:10.1371/journal.pone.0025265.g006
Multi-Potent Sca-1
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ation [5]. These cells co-cultured with cardiomyocytes were indeed
transformed into myocytes (Figure 6D). Although we only
considered a-sarcomeric actinin positive cell with single nucleus
as the differentiated cell, we could not rule out the possibility that
these a-sarcomeric actinin positive cells were formed by fusion
with co-cultured cardiomyocytes. In order to exclude the
possibility of cell fusion between multipotent cardiac stem/
progenitor cells and living cardiomyocytes, we co-cultured cardiac
stem/progenitor cells with paraformaldehyde-fixed neonatal rat
cardiomyocytes with cardiomyocytes conditioned medium [5].
These results showed that both secreted factors in the cardiomy-
ocyte conditioned medium and the membrane bound factors in
the cardiomyocytes were essential for induction of cardiomyogenic
differentiation of multipotent stem cells. One week after co-
culture, small number (similar to co-culture with living cardiomy-
ocyte) of CSH2 cell population stained positively for a-sarcomeric
actinin (Figure 6D). These data suggested that CSH2 cell
population really harbored true immature cell population which
differentiated into cardiomyocytes under optimal conditions.
Despite promising data, the study has some limitations.
Although the cells showed cardiomyogenic regeneration capacity
and therapeutic effects post-engraftment, the frequency of
cardiomyogenic differentiation of CSH2 cells in vitro conditions
was lower than our anticipation. Although the underlying reason is
unclear, a recently published study using four cardiac progenitor
cell types including Isl-1
+/Nkx2.5
2, Isl-1
2/Nkx2.5
+, Isl-1
+/
Nkx2.5
+, and Isl-1
2/Nkx2.5
2 cells to compare their differentia-
tion capacity into cardiomyocytes and smooth muscle cells under
two different culture conditions [32]. Interestingly, only Isl-1
+/
Nkx2.5
2 cardiac progenitor cells showed significant increase in
cardiomyogenic differentiation under specific culture conditions.
The authors suggested that the cardiomyogenic potential of Isl-1
+/
Nkx2.5
2 was modulated by microenviromental geometric cues.
These observations supported our results that CSH2 with Isl-1
+/
Nkx2.5
2 cells represented a true population of cardiac progenitor
cells. Secondly, inspite of immunohistological evidence that about
cardiomyogenic differentiation, future studies would be required
showing functional integration of the differentiated cells. Lastly, a
direct comparison of the clonally selected Sca-1
+ cells with MACS
sorted Sca-1
+ cells would further show the significance of our new
method of Sca-1+ cell purification.
In conclusion, we have demonstrated that adult mouse heart
harbors Sca-1
+/Isl-1
+/Nkx2.5
2 cells with their unique functional
features, clonality and self-renewal capacity. This cell population
originated from cells of secondary heart field and showed
multilineage differentiation potential. Transplantation of these
cells into infarcted heart significantly preserved the heart function
and attenuated infarction size expansion. Further investigation
into the potential of adult heart-derived Sca-1
+/Isl-1
+/Nkx2.5
2
stem/progenitor cells would be required to utilize these promising
candidates for the heart cell therapy.
Supporting Information
Figure S1 Differentiation potential of isolated Sca-1
high or low expressing cell populations into smooth
muscle cell lineage. A, All cell populations were stained for
smooth muscle cell specific marker calponin (green) and DAPI
(blue) both before induction (Control) and after induction
(Induction). Magnification=6400. B, Calponin positive cell
number was calculated in all cell populations both before
induction (Control) and after induction (Induction). The positive
rate was presented as the ratio of calponin positive cell number to
total cell number (*p,0.01 vs Control; **p,0.05 vs Control;
{p,0.01 vs all other cell populations; {p,0.01 vs CSH1, CSH2,
and CSL1; 1p,0.01 vs CSH2 and CSL1). C, Expression of smooth
muscle cell specific genes analyzed by RT-PCR. RNA extracted
from whole heart of adult mouse (mH) was used as positive
control.
(TIF)
Figure S2 Differentiation potential of isolated Sca-1
high or low expressing cell populations into endothelial
cell lineage. A, All cell populations were stained for endothelial
cell specific marker von Willebrand Factor (green) and DAPI (blue)
after induction. Magnification=6400. B, vWF positive cell
number was calculated before induction (Control) and after
induction (Induction). The positive rate was presented as the ratio
of vWF positive cells to total cell number (*p,0.01 vs Control,
{p,0.01 vs all other cell populations). C, Expression of endothelial
cell specific genes analyzed by RT-PCR. RNA extracted from
whole heart of adult mouse (mH) was used as positive control.
Arrow indicated the expression of endothelial cell specific genes
after induction.
(TIF)
Text S1 Supporting Information.
(DOC)
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